Rothschild Investment LLC’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.06K Buy
269
+136
+102% +$2.38K ﹤0.01% 2402
2026
Q1
$2.55K Buy
133
+10
+8% +$217 ﹤0.01% 2435
2025
Q4
$2.7K Buy
123
+98
+392% +$1.77K ﹤0.01% 2212
2025
Q3
$304 Sell
25
-100
-80% -$1.35K ﹤0.01% 2934
2025
Q2
$2.33K Buy
125
+95
+317% +$1.88K ﹤0.01% 1969
2025
Q1
$575 Sell
30
-40
-57% -$1.17K ﹤0.01% 2577
2024
Q4
$2.52K Buy
70
+20
+40% +$677 ﹤0.01% 1662
2024
Q3
$2.12K Buy
50
+40
+400% +$1.7K ﹤0.01% 1689
2024
Q2
$403 Buy
+10
New +$417 ﹤0.01% 2154

Other funds holding TNDM

Rothschild Investment LLC's TNDM Position: Q2 2026 in Review

Rothschild Investment LLC increased its Tandem Diabetes Care (TNDM) stake by 102% in Q2 2026, buying an estimated $2.38K and bringing the position to 269 shares worth $4.06K. The position accounts for ﹤0.01% of the portfolio, ranked #2402.

Rothschild Investment LLC first reported a position in TNDM in Q2 2024 and has held it in 9 quarters since. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Rothschild Investment LLC held 269 shares of Tandem Diabetes Care worth $4.06K as of Q2 2026.
  • Rothschild Investment LLC bought 136 Tandem Diabetes Care shares in Q2 2026, an estimated $2.38K.
  • Tandem Diabetes Care made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2402 holding.
  • Rothschild Investment LLC first reported a position in Tandem Diabetes Care in Q2 2024 and has held it in 9 quarters since.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.